China is fast becoming a global leader in producing cutting-edge medicine, with nearly half of the world’s new drugs in testing now emerging from its labs. But can it replicate in pharmaceuticals what it has achieved in electric vehicles and robotics with faster and cheaper innovation? CNA Senior Correspondent Tan Yew Guan joins Otelli Edwards in this week’s episode of the CNA Correspondent podcast to explore China’s biotech ambitions and its push to make breakthrough treatments both accessible and affordable.